Long‐term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model for amyotrophic lateral sclerosis
Authors:
- Barbara BonamassaBBBarbara Bonamassa
- Emiliano Pena‐AltamiraEPEmiliano Pena‐Altamira
- Moreno PaoliniMPMoreno Paolini
- Antonio ContestabileACAntonio Contestabile
- 18 March 2009
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 39 (4) , 548-552
Abstract
Mice bearing the mutated gene for Cu/Zn superoxide dismutase (G93A) are a good model for human amyotrophic lateral sclerosis (ALS). They develop progressive limb paralysis paralleled by loss of motor neurons of the cervical and lumbar spinal cord, which starts at 3–3.5 months of age and ends with death at 4–5 months. Several treatments have been attempted to delay clinical symptoms and to extend lifespan, and some have had modest beneficial effects. One such treatment, based on long‐term administration of valproic acid (VPA), resulted in controversial results. We report here that, while dietary supplementation with high VPA dosage slows down motor neuron death, as assessed by measurement of a specific marker for cholinergic neurons in the spinal cord, it has no significant effect on lifespan. Recently, the hypothesis has been put forward that a deficiency of retinoic acid (RA) and its signaling may have a role in ALS. We report that long‐term dietary supplementation with RA has no effect on the decrease of the cholinergic marker in the spinal cord, but it significantly shortens lifespan of G93A mice. Muscle Nerve 39: 548–552, 2009Keywords
This publication has 28 references indexed in Scilit:
- Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathwayBiochemical Pharmacology, 2008
- Amyotrophic lateral sclerosis models and human neuropathology: similarities and differencesActa Neuropathologica, 2007
- Retinoic acid in the development, regeneration and maintenance of the nervous systemNature Reviews Neuroscience, 2007
- Retinoid receptors in chronic degeneration of the spinal cord: observations in a rat model of amyotrophic lateral sclerosisJournal of Neurochemistry, 2007
- Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn‐superoxide dismutase mutant G93A mouseMuscle & Nerve, 2004
- Gene–Diet Interactions in Brain Aging and Neurodegenerative DisordersAnnals of Internal Medicine, 2003
- Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arraysJournal of Neurochemistry, 2001
- Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arraysJournal of Neurochemistry, 2001
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993
- A rapid radiochemical method for the determination of choline acetyltransferaseJournal of Neurochemistry, 1975